Idiopathic pulmonary fibrosis (IPF) is a progressive lung disease with a poor prognosis.
Lung transplantation is the only intervention shown to increase life expectancy for patients …

ABSTRACT Introduction: Idiopathic Pulmonary Fibrosis (IPF) is a unique type of interstitial
pneumonia in which progressive fibrosis can ultimately result in respiratory failure and …

Background Idiopathic pulmonary fibrosis (IPF) is a distinct form of interstitial pneumonia
with unknown origin and poor prognosis. Current pharmacologic treatments are limited and …

Interstitial lung disease (ILD) has been reported to have a poor outcome following lung
transplantation due to difficulties getting ill recipients to transplantation and challenging …

Idiopathic pulmonary fibrosis (IPF) remains the most common of the idiopathic interstitial
pneumonias and portends a poor prognosis. Significant strides have been made in the …

Idiopathic pulmonary fibrosis (IPF) is a fibrotic lung disease of unknown cause characterized
by relentlessly progressive restrictive-ventilatory limitation, hypoxia, dyspnea, and cough …

Objective To review the present status of lung transplant (LTx) in patients with idiopathic
pulmonary fibrosis (IPF). Data Sources Current English-language literature review using …

BACKGROUND: Outcomes of lung transplantation for idiopathic pulmonary fibrosis (IPF) are
thought to be worse than those for other indications, although the reasons are unknown. In …

Background Following recent approval of pirfenidone and nintedanib for idiopathic
pulmonary fibrosis (IPF), questions arise about the use of these antifibrotics in patients …

Lung transplantation (LTx) can be a life-extending treatment option for patients with
advanced and/or progressive fibrotic interstitial lung disease (ILD), especially idiopathic …